Caldwell William S
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Caldwell William S. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| GYRE | SVP - Drug Discovery and Dev. | Gift | 500 | — | — | Sep 20, 2011 |
| GYRE | SVP - Drug Discovery and Dev. | Sale | 2,655 | $26.37 | $70,012 | Mar 31, 2011 |
| GYRE | SVP - Drug Discovery and Dev. | Option Exercise | 11,360 | $8.51 | $96,674 | Mar 1, 2011 |
| GYRE | SVP - Drug Discovery and Dev. | Option Exercise | 16,655 | $1.75 | $29,146 | Feb 16, 2011 |
| GYRE | SVP - Drug Discovery and Dev. | Option Exercise | 12,000 | $1.75 | $21,000 | Dec 13, 2010 |
| GYRE | SVP - Drug Discovery and Dev. | Option Exercise | 14,278 | $8.51 | $121,506 | Apr 30, 2010 |
| GYRE | SVP - Drug Discovery and Dev. | Sale | 16,000 | $24.00 | $384,000 | Apr 29, 2010 |
| GYRE | SVP - Drug Discovery and Dev. | Sale | 315 | $24.00 | $7,560 | Apr 26, 2010 |
| GYRE | SVP - Drug Discovery and Dev. | Option Exercise | 7,245 | $5.10 | $36,950 | Apr 20, 2010 |
| GYRE | SVP - Drug Discovery and Dev. | Option Exercise | 36,946 | $5.10 | $188,425 | Apr 16, 2010 |
| GYRE | VP - Drug Discovery and Dev. | Sale | 23,201 | $21.93 | $508,798 | Dec 16, 2009 |
| GYRE | VP - Drug Discovery and Dev. | Sale | 23,206 | $21.93 | $508,908 | Dec 16, 2009 |
| GYRE | VP - Drug Discovery and Dev. | Option Exercise | 2,100 | $1.75 | $3,675 | Sep 4, 2009 |
| GYRE | VP - Drug Discovery and Dev. | Sale | 13,955 | $14.54 | $202,906 | Aug 31, 2009 |
| GYRE | VP - Drug Discovery and Dev. | Option Exercise | 1,600 | $1.75 | $2,800 | Aug 28, 2009 |
| GYRE | VP - Drug Discovery and Dev. | Sale | 1,600 | $14.00 | $22,400 | Aug 28, 2009 |
| GYRE | VP - Drug Discovery and Dev. | Option Exercise | 4,595 | $2.93 | $13,463 | Aug 11, 2009 |
| GYRE | VP - Drug Discovery and Dev. | Option Exercise | 771 | $1.75 | $1,349 | Aug 7, 2009 |
| GYRE | VP - Drug Discovery and Dev. | Sale | 693 | $12.00 | $8,316 | Jul 29, 2009 |